EGFR and colorectal carcinoma: In line with our observations, recent studies demonstrated that EGFR inhibition can induce quiescence of LGR5+ murine intestinal stem cells8 and that treatment with cetuximab and genetic ablation of LGR5 synergistically enhanced CRC eradication59.